U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Protein
Created
by admin
on Wed Apr 02 11:38:21 GMT 2025
Edited
by admin
on Wed Apr 02 11:38:21 GMT 2025
Protein Type MONOCLONAL ANTIBODY CONJUGATE
Protein Sub Type IGG1|KAPPA
Sequence Origin HUMANIZED MOUSE
Sequence Type COMPLETE
Record UNII
96ZG83EF42
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Sonesitatug Vedotin
INN  
Official Name English
An anti-Claudin 18.2 monoclonal antibody conjugated with MMAE payload
Preferred Name English
immunoglobulin G1-kappa, anti-[Homo sapiens CLDN18 (claudin 18, claudin-18, surfactant associated protein J, SFTPJ) isoform 2], humanized monoclonal antibody, conjugated on an average of four cysteinyl residues to vedotin, comprising a cleavable linker a
Common Name English
Immunoglobulin G1, anti-(human claudin CLDN18) (human-Mus musculus monoclonal CM311 ?1-chain), disulfide with human-Mus musculus monoclonal CM311 ?-chain, dimer, thioether with N-[[[4-[[N-[6-(3-mercapto-2,5-dioxo-1-pyrrolidinyl)-1-oxohexyl]-L-valyl-N5-(a
Common Name English
sonesitatug vedotin [INN]
Common Name English
H-gamma1 heavy chain humanized (1-448) [VH (Homo sapiens IGHV4-59*11 (94.8%) -(IGHD) -IGHJ4*01 (92.9%), CDR-IMGT [9.7.11] (26-34.52-58.97-107)) (1-118) -Homo sapiens IGHG1*03 (100%) G1m3, nG1m1 CH1 R120, CH3 E12, M14 (CH1 R120 (215) (119-216), hinge 1-15
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 871122
Created by admin on Wed Apr 02 11:38:21 GMT 2025 , Edited by admin on Wed Apr 02 11:38:21 GMT 2025
Code System Code Type Description
SMS_ID
300000052801
Created by admin on Wed Apr 02 11:38:21 GMT 2025 , Edited by admin on Wed Apr 02 11:38:21 GMT 2025
PRIMARY
INN
12846
Created by admin on Wed Apr 02 11:38:21 GMT 2025 , Edited by admin on Wed Apr 02 11:38:21 GMT 2025
PRIMARY
NCI_THESAURUS
C180413
Created by admin on Wed Apr 02 11:38:21 GMT 2025 , Edited by admin on Wed Apr 02 11:38:21 GMT 2025
PRIMARY
CAS
2813237-93-1
Created by admin on Wed Apr 02 11:38:21 GMT 2025 , Edited by admin on Wed Apr 02 11:38:21 GMT 2025
PRIMARY
FDA UNII
96ZG83EF42
Created by admin on Wed Apr 02 11:38:21 GMT 2025 , Edited by admin on Wed Apr 02 11:38:21 GMT 2025
PRIMARY
From To
1_22 1_96
2_22 2_96
2_145 2_201
2_221 4_220
2_262 2_322
1_145 1_201
2_368 2_426
3_23 3_94
3_140 3_200
4_23 4_94
4_140 4_200
1_221 3_220
1_227 2_227
1_230 2_230
1_262 1_322
1_368 1_426
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_298
N 2_298
Related Record Type Details
ACTIVE MOIETY

Structural Modifications

Modification Type Location Site Location Type Residue Modified Extent Fragment Name Fragment Approval
AMINO_ACID_SUBSTITUTION RESIDUE_SPECIFIC C Amount: Cysteinyl vedotin 6603L01WUR
AMINO_ACID_SUBSTITUTION [1_1] [2_1] N-TERMINUS PIDOLIC ACID SZB83O1W42
AMINO ACID REMOVAL [1_448] [2_448] C-TERMINUS Amount: LYSINE K3Z4F929H6
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL